medigraphic.com
ISSN 2007-8560 (Print)
Órgano Oficial de Difusión Científica de la Federación Mexicana de Colegios de Ortopedia y Traumatología, A.C. (FEMECOT)

2019, Number 2

<< Back Next >>

Ortho-tips 2019; 15 (2)

Surgical treatment of hip fracture due to osteoporosis

Nieto LL, Reyes PE, Aguilar EGV, Torres GR

Language: Spanish
References: 13
Page: 105-111
PDF size: 129.05 Kb.


ABSTRACT

Osteoporosis is a disease characterized by loss of bone mass. The detection of the first fracture represents, in the majority of cases, the first opportunity for the care and timely treatment of osteoporosis. A fragility fracture is defined as any fall from a standing height or less, resulting in a fracture. Surgical management of bone fragility fractures, with adequate implant selection according to the personality of a fracture, remains the treatment of choice in the majority of patients with hip fractures in our environment. Breaking the barriers of discrimination of the individualized management by the orthopedist and converting it into a multidisciplinary management with the support of the internal medicine professional or geriatrician for the benefit of the patient is paramount in helping to improve the morbidity and mortality of the patient with fragility who is currently suffering from a fracture of hip.


REFERENCES

  1. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. Geneva: WHO, 1994 (Technical Report Series 843). In: Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285: 785-795.

  2. International Osteoporosis Foundation. Osteoporosis and Musculoskeletal disorders. [En línea] [Acceso Julio 2017] http://www.iofbonehealth.org/facts-statistics.

  3. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17: 1726-1733.

  4. Cooper MS, Palmer AJ, Seibel MJ. Cost-effectiveness of the concord minimal trauma fracture liaison service, a prospective, controlled fracture prevention study. Osteoporos Int. 2012; 23: 97-107.

  5. Xia WB, He SL, Xu L, Liu AM, Jiang Y, Li M, et al. Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res. 2012; 27: 125 -129.

  6. Strom O, Borgstrom F, Kanis JA, Compston J, Cooper C, McCloskey EV, et al. Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2011; 6: 59-155.

  7. Binkley N, Blank RD, Leslie WD, Lewiecki EM, Eisman JA, Bilezikian JP. Osteoporosis in crisis: it’s time to focus on fracture. J Bone Miner Res. 2017; 32 (7): 1391-1394.

  8. Schnell S, Friedman SM, Mendelson DA, Bingham KW, Kates SL. The 1-yearmortality of patients treated in a hip fracture program for elders. Geriatr Orthop Surg Rehabil. 2010; 1 (1): 6-14.

  9. Cooper C, et al. Population-based study of survival following osteoporotic fracture. Am J Epidemiol. 1993; 137: 1001-1005.

  10. Van Staa TP, et al. Epidemiology of fractures in England and Wales. Bone. 2001; 29: 517-522.

  11. Estadísticas del IMSS, consultado vía internet el 26 de julio del 2018. Disponible en: http://www.imss.gob.mx/conoce-al-imss.

  12. Perren SM. Backgrounds of the technology of internal fixators. Injury. 2003; 34 (Suppl. 2): 1-3.

  13. Chapman JR, Harrington RM, Lee JM, et al. Factors affecting the pullout strength of cancellous bone screws. J Biomech Eng. 1996; 118: 391-398.




2020     |     www.medigraphic.com